Gastrointestinal bleeding during anti-angiogenic peptide vaccination in combination with gemcitabine for advanced pancreatic cancer-Reference-Cited by-同舟云学术

Gastrointestinal bleeding during anti-angiogenic peptide vaccination in combination with gemcitabine for advanced pancreatic cancer

Published:2010-09-25 Issue:6 Volume:3 Page:307-317
ISSN:1865-7257
Container-title:Clinical Journal of Gastroenterology
language:en
Short-container-title:Clin J Gastroenterol

Author:

Nagayama Hitomi,Matsumoto Kazufumi,Isoo Naoyuki,Ohno Hideki,Takahashi Naoyuki,Nakaoka Takashi,Shinozaki Masaru,Watanabe Makoto,Inoue Yusuke,Nagamura Fumitaka,Oyaizu Naoki,Yamashita Naohide

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12328-010-0178-5.pdf

Reference41 articles.

1. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Database Report on pancreatic cancer. Cancer. 1995;76:1671–7.

2. Shaib YH, Davila JA, El-Serag HB. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther. 2006;24:87–94.

3. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403–13.

4. Di Marco M, Di Cicilia R, Macchini M, Nobili E, Vecchiarelli S, Brandi G, et al. Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? (Review). Oncol Rep. 2010;23:1183–92.

5. Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials group. J Clin Oncol. 2007;25:1960–6.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Robo4 vaccines induce antibodies that retard tumor growth;Angiogenesis;2014-10-28

2. Robo4 is an effective tumor endothelial marker for antibody-drug conjugates based on the rapid isolation of the anti-Robo4 cell-internalizing antibody;Blood;2013-04-04

3. Antigen dose escalation study of a VEGF-based therapeutic cancer vaccine in non human primates;Vaccine;2012-01

4. Sharing information on adverse events;The Lancet;2011-05